Dopa-responsive dystonia

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 539-557

  Segawa, Masaya ^a  

^a Segawa Neurological Clinic for Children   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; DOPAMINE RECEPTOR STIMULATING AGENT;

BIOLOGICAL MODEL; BOOK; CHEMICALLY INDUCED DISORDER; DYSTONIA; HUMAN;

DIHYDROXYPHENYLALANINE; DOPAMINE AGENTS; DYSTONIA; HUMANS; MODELS, BIOLOGICAL;

EID: 79954463100     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00039-2     Document Type: Book

References (155)

1. Abeling N.G., Duran M., Bakker H.D., et al. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. Mol Genet Metab 2006, 89:116-120.
2. Bandmann O., Nygaard T.G., Surtees R., et al. Dopa responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996, 5:403-406.
3. Bandmann O., Valene E.M., Holmans P., et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998, 44:649-656.
4. Blau N., Barnes I., Dhondt J.L. International database of tetrahydrobiopterin deficiencies. J Inherit Metab Dis 1996, 19:8-14.
5. Blau N., Bonafe L., Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 2001, 74:172-185.
6. Bonafe L., Thony B., Penzien J.M., et al. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 2001, 69:269-277.
7. Brautigam C., Wevers R.A., Jansen R.J., et al. Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem 1998, 44:1897-1904.
8. Brautigam C., Steenbergen-Spanjers G.C., Hoffmann G.F., et al. Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Clin Chem 1999, 45:2073-2078.
9. Brenner E., Mirmiran M., Uylings H.B., et al. Impaired growth of the cerebral cortex of rats treated neonatally with 6-hydroxydopamine under different environmental conditions. Neurosci Lett 1983, 42:13-17.
10. Calne D.B. Dopa-responsive dystonia. Ann Neurol 1994, 35:381-382.
11. Castaigne P., Rondot P., Ribadeau-Dumas J.L., et al. [Progressive extra-pyramidal disorder in 2 young brothers. Remarkable effects of treatment with levodopa]. Rev Neurol (Paris) 1971, 124:162-166.
12. Chaila E.C., McCabe D.J., Delanty N., et al. Broadening the phenotype of childhood-onset dopa-responsive dystonia. Arch Neurol 2006, 63:1185-1188.
13. Cheyette B.N., Cheyette S.N., Cusmano-Ozog K., et al. Dopa-responsive dystonia presenting as delayed and awkward gait. Peiatr Neurol 2008, 38:273-275.
14. Chien Y.H., Chiang S.C., Huang A., et al. Treatment and outcome of Taiwanese patients with 6-pyruvoyltetrahydropterin synthase gene mutations. J Inherit Metab Dis 2001, 24:815-823.
15. Cotton R.G., Jennings I., Bracco G., et al. Tetrahydrobiopterin non-responsiveness in dihydropteridine reductase deficiency is associated with the presence of mutant protein. J Inherit Metab Dis 1986, 9:239-243.
16. Curtius H.C., Blou N., Kuster T. Pterins. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory manual 1991, 377-379. Wiley-Liss, NewYork, NY. F.A. Hommes (Ed.).
17. Davis M.D., Ribeiro P., Tipper J., et al. " 7-tetrahydrobiopterin," a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases. Proc Natl Acad Sci U S A 1992, 89:10109-10113.
18. Demos M.K., Waters P.J., Vallance H.D., et al. 6-pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia. Ann Neurol 2005, 58:164-167.
19. Deonna T. Dopa-responsive progressive dystonia of childhood with fluctuations of symptoms - Segawa's syndrome and possible variants. Neuropediatrics 1986, 17:81-85.
20. Dionisi-Vici C., Hoffmann G.F., Leuzzi V., et al. Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr 2000, 136:560-562.
21. Dudesek A., Roschinger W., Muntau A.C., et al. Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. Eur J Pediatr 2001, 160:267-276.
22. Farrer M., et al. Lewy bodies and Parkinsonism in families with parkin mutations. Ann Neurol 2001, 50:293-300.
23. Farrugia R., Scerri C.A., Montalto Sa, et al. Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population. Mol Genet Metab 2007, 90:277-283.
24. Fink J.K., Barton N., Cohen W., et al. Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 1988, 38:707-711.
25. Fujita S., Shintaku H. Etiology and pteridine metabolism abnormality of hereditary progressive dystonia with marked diurnal fluctuation (HPD: Segawa disease). Med J Kushiro City Hosp 1990, 2:64-67.
26. Furukawa Y. Genetics and biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss. Adv Neurol 2003, 91:401-410.
27. Furukawa Y., Kish S.J. Dopa-responsive dystonia: recent advances and remaining issues to be addressed. Mov Disord 1999, 14:709-715.
28. Furukawa Y., Nishi K., Kondo T., et al. CSF biopterin levels and clinical features of patients with juvenile parkinsonism. Adv Neurol 1993, 60:562-567.
29. Furukawa Y., Shimadzu M., Rajput A.H., et al. GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa responsive dystonia. Ann Neurol 1996, 39:609-617.
30. Furukawa Y., Kish S.J., Bebin E.M., et al. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol 1998, 44:10-16.
31. Furukawa Y., Lang A.E., Trugman J.M., et al. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology 1998, 50:1015-1020.
32. Furukawa Y., Nygaard T.G., Gutlich M., et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 1999, 53:1032-1041.
33. Furukawa Y., Guttman M., Sparagana S.P., et al. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol 2000, 47:517-520.
34. Furukawa Y., Graf W.D., Wong H., et al. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase gene mutations. Neurology 2001, 56:260-263.
35. Furukawa Y., Kapatos G., Haycock J.W., et al. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Ann Neurol 2002, 51:637-641.
36. Furukawa Y., Filiano J.J., Kish S.J. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Mov Disord 2004, 19:1256-1258.
37. Gibb W.R.G. Selective pathology, disease pathogenesis and function in the basal ganglia. Recent Advances in Clinical Neurophysiology 1996, 1009-1015. Elsevier, Amsterdam. J. Kimura, H. Shibasaki (Eds.).
38. Givanniello T., Leuzzi V., Carducci C., et al. Tyrosine hydroxylase deficiency presenting with a biphasic clinical course. Neuropediatrics 2007, 38:213-215.
39. Grattan-Smith P.J., Wevers R.A., Steenbergen-Spanjers G.C., et al. Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy. Mov Disord 2002, 17:354-359.
40. Graybiel A.M., Ragsdale C.W. Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci 1978, 75:5723-5726.
41. Grötzsch H., Pizzolato G.P., Ghika J., et al. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002, 58:1839-1842.
42. Hanajima R., Nomura Y., Segawa M., et al. Intracortical inhibition of the motor cortes in Segawa disease (DYT5). Neurology 2007, 68:1039-1044.
43. Hanihara T., Inoue K., Kawanishi C., et al. 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study. Mov Disord 1997, 12:408-411.
44. Hikosaka O., Sakamoto M., Usui S. Functional properties of monkey caudate neurons. I. Activities related to saccadic eye movements. J Neurophysiol 1989, 61:780-798.
45. Hikosaka O., Fukuda H., Kato M., et al. Deficits in saccadic eye movements in hereditary progressive dystonia with marked diurnal fluctuation. Hereditary Progressive Dystonia with Marked Diurnal Fluctation 1993, 159-177. Parthenon, Carnforth. M. Segawa (Ed.).
46. Hirano M., Tamura Y., Nagai Y., et al. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa responsive dystonia. Biochem Biphys Res Commun 1995, 213:645-646.
47. Hirano M., Tamaru Y., Ito H., et al. Mutant GTP cyclohydrolase I mrna levels contribute to dopa-responsive dystonia onset. Ann Neurol 1996, 40:796-798.
48. Hirano M., Yanagihara T., Ueno S. Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia. Ann Neurol 1998, 44:365-371.
49. Hjermind L.E., Johannsen L.G., Blau N., et al. Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?. Mov Disord 2006, 21:679-682.
50. Hoffmann G.F., Assmann B., Brautigam C., et al. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 2003, 54:56-65.
51. Hornykiewicz O. Striatal dopamine in dopa-responsive dystonia: Comparison with idiopathic Parkinson's disease and other dopamine-dependent disorders. Age-Related Dopamine-Dependent Disorders 1995, 101-108. Karger, Basel. M. Segawa, Y. Nomura (Eds.).
52. Huang Y.Z., Trender-Gerhard I., Edwards M.J., et al. Motor system inhibition in dopa-responsive dystonia and its modulation by treatment. Neurology 2006, 66:1088-1090.
53. Hwu W.L., Chiou Y.W., Lai S.Y., et al. Dopa-responsive dystonia is induced by a dominant-negative mechanism. Ann Neurol 2000, 48:609-613.
54. Hyland K., Fryburg J.S., Wilson W.G. Oral phenylalanine loading in Dopa responsive dystonia; a possible diagnostic test. Neurology 1997, 48:1290-1297.
55. Ibi T., Sahashi K., Watanabe K., et al. [Progressive dystonia with marked diurnal fluctuation and tetrahydrobiopterin therapy]. Neurol Ther (Tokyo) 1991, 8:71-75.
56. Ichinose H., Ohye T., Takahashi E., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994, 8:236-242.
57. Ichinose H., Ohye T., Segawa M., et al. GTP chclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Let 1995, 196:5-8.
58. Ishida A., Takada G., Kobayashi Y., et al. [Involvement of serotonergic neurons in hereditary progressive dystonia; Clinical effects of tetrahydrobiopterin and 5-hydroxytryptophan]. No-To-Hattatsu (Tokyo) 1988, 20:196-199.
59. Janssen R.J., Wevers R.A., Haussler M., et al. A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet 2000, 64:375-382.
60. 123I] β-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998, 43:792-800.
61. Kikuchi A., Takeda A., Fujihara K., et al. Arg(184) His mutant GTP cyclohydrolase I causing recessive hyperphenylalaninemia is responsible for dopa-responsive dystonia with parkinsonism: a case report. Mov Disord 2003, 19:590-593.
62. 11C] raclopride and positron-emission tomography. Neurology 1998, 50:1028-1032.
63. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
64. Knappskog P.M., Flatmark T., Mallet J., et al. Recessively inherited LEVODOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995, 4:1209-1212.
65. Kobayashi K., Yasoshima Y., Kai N., et al. Subthalamic neurons coordinate basal ganglia function through differential neural pathways. J Neurosci 2005, 25:7743-7753.
66. Kondo T., Mori H., Sugita Y., et al. Juvenile Parkinsonian - A clinical, neuropathological, and biochemical study. Mov Disord 1997, 12:32.
67. Kreiss D.S., Anderson L.A., Waters J.R. Apomorphine and dopamine D receptor agonists increase the firing rates of subthalamic neucleus neurons. Neuroscience 1996, 72:863-876.
68. Kumamoto I., Nomoto M., Yoshidome M., et al. [Five cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF]. Clin Neurol (Tokyo) 1984, 24:697-702.
69. Kunig G., Leenders K.L., Antonini A., et al. D2 receptor binding in dopa-responsive dystonia. Ann Neurol 1988, 44:758-762.
70. Leenders K.L., Antonini A., Meinck, et al. Striatal dopamine D2 receptors in dopa-responsive dystonia and Parkinson's disease. Age-Related Dopamine-Dependent Disorders 1995, 95-100. Karger, Basel. M. Segawa, Y. Nomura (Eds.).
71. Leff S.E., Rendahl K.G., Spratt S.K., et al. In vivo levodopa production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of gtpcyclohydrolase I with tyrosine hydroxylase. Exp Neurol 1998, 151:249-264.
72. Lenz F.A., Seike M.S., Jaeger C.J., et al. Single unit analysis of thalamus in patients with dystonia. Mov Disord 1992, 7:126.
73. Leuzzi V., Carducci C., Carducci C., et al. Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology 2002, 59:1241-1243.
74. LeWitt P.A., Miller L.P., Newman R.P., et al. Pteridine cofactor in dystonia: Pathogenic and therapeutic considerations. Neurology 1983, 33:161.
75. LeWitt P.A., Miller L.P., Newman R.P., et al. Treatment of dystonia with tetrahydrobiopterin. N Engl J Med 1983, 308:157-158.
76. LeWitt P.A., Miller L.P., Newman R.P., et al. Tetrahydrobiopterin in dystonia: Identification of abnormal metabolism and therapeutic trials. Neurology 1986, 36:760-764.
77. Liu K.M., Liu T.T., Lee N.C., et al. Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyltetrahydropterin synthase deficiency. Arch Neurol 2008, 65:387-392.
78. Liu T.T., Chang Y.H., Chiang S.H., et al. Identification of three novel 6-pyruvoyl-tetrahydropterin synthase gene mutations (226C>T, IVS3+1G>A, 116-119deltgtt) in Chinese hyperphenylalaninemia caused by tetrahydrobiopterin synthesis deficiency. Hum Mutat 2001, 18:83.
79. Lopez-Laso E., Camino R., Mateos M.E., et al. Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency. J Neurol Sci 2007, 256:90-93.
80. Ludecke B., Knappskog P.M., Clayton P.T., et al. Recessively inherited LEVODOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 1996, 5:1023-1028.
81. Maekawa K., Hashimoto T., Sasaki M., et al. [A study on catecholamine metabolites in CSF in a patient with progressive dystonia with marked diurnal fluctuation]. Clin Neurol (Tokyo) 1988, 28:1206-1208.
82. Mason S.T. Noradrenaline and behaviour. Trends Neurosci 1979, 2:82-84.
83. Matsumine M., Saito M., Shimoda-Matsubayashi S., et al. Localization of a gene for an autosomal recessive from of juvenile parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 1997, 60:588-596.
84. McGeer E.G., McGeer P.L. Some characteristics of brain tyrosine hydroxylase. New Concepts in Neurotransmitter Regulation 1973, 53-68. Plenum, New York. J. Mandel (Ed.).
85. Mizuno Y., Hattori N., Kubo S., et al. Progress in the pathogenesis and genetic of Parkinson's disease. Phil Trans R Son B 2008, 363:2215-2227.
86. Mori S., Matsuyama K., Kohyama J., et al. Neuronal constituents of postural and locomotor control systems and their interactions in cats. Brain Dev 1992, 14:109-120.
87. Muller K., Homberg V., Lenard H.G. Motor control in childhood onset dopa-responsive dystonia (Segawa syndrome). Neuropediatrics 1989, 20:185-191.
88. Nagata E., Kosakai A., Tanaka K., et al. Dopa-responsive dystonia (Segawa disease)-like disease accompanied by mental retardation: a case report. Mov Disord 2007, 22:1202-1203.
89. Narabayashi H., Yokochi M., Iizuka R., et al. Juvenile parkinsonism. Handbook of Clinical Neurology 1986, Vol. 5:153-165. Elsevier Science, Amsterdam.
90. Neville B.G., Parascandalo R., Farrugia R., et al. Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder. Brain 2005, 128:2291-2296.
91. Niederwieser A., Blau N., Wang M., et al. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. 1. Eur J Pediatr 1984, 141:208-214.
92. Nishiyama N., Yukishita S., Hagiwara S., et al. Gene mutation in hereditary progressive dystonia with marked diurnal fluctuation (HPD), strictly defined dopa-responsive dystonia. Brain Dev 2000, 22:102-106.
93. Nomura K., Negoro T., Takesu E., et al. Bromocriptine therapy in a case of hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 1987, 9:199.
94. Nomura Y., Segawa M. Intrafamilial and interfamilial variations of symptoms of Japanese hereditary progressive dystonia with marked diurnal fluctuation. Hereditary Progressive Dystonia with Marked Diurnal Fluctation 1993, 73-96. Parthenon, Carnforth. M. Segawa (Ed.).
95. Nomura Y., Kase M., Igawa C., et al. A female case of hereditary progressive dystonia with marked diurnal fluctuation with favorable response to anticholinergic drugs for 25 years. Clin Neurol 1984, 22:723.
96. Nomura Y., Uetake K., Yukishita S., et al. Dystonias responding to levodopa and failure in biopterin metabolism. Adv Neurol 1998, 78:253-266.
97. Nomura Y., Ikeuchi T., Tsuji S., et al. Two phenotypes and anticipation observed in Japanese cases with early-onset torsion dystonia (DYT 1). Brain Dev 2000, 22:92-101.
98. Nygaard T.G., Wilhelmsen K.C., Risch N.J., et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993, 5:386-391.
99. Nygaard T.G., Marsden C.D., Duvoisin R.C. Dopa responsive dystonia. Adv Neurol 1988, 50:377-384.
100. Nygaard T.G., Waran S.P., Levine R.A., et al. Dopa-responsive dystonia simulating cerebral palsy. Pediatr Neurol 1994, 11:236-240.
101. O'Sullivan J.D., Costa D.C., Gacinovic S., et al. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. Neurology 2001, 56:266-267.
102. Okada A., Nakamura K., Snow B.J., et al. PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease): case report. Adv Neurol 1993, 60:591-594.
103. Oppliger T., Thony B., Kluge C., et al. Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency in four Italian families. Hum Mutat 1997, 10:25-35.
104. Ouvrier R.A. Progressive dystonia with marked diurnal fluctuation. Ann Neurol 1978, 4:412-417.
105. Postuma R.B., Furukawa Y., Rogaeva E., et al. Dopa-responsive dystonia presenting with prominent isolated bilateral resting leg tremor: evidence for a role of parkin?. Mov Disord 2003, 18:1069-1072.
106. Rajput A.H., Gibb W.R.G., Zhong X.H., et al. Dopa-responsive dystonia: pathological and biochemical observations in one case. Ann Neurol 1994, 35:396-402.
107. Reisert I., Pilgrim C. Sexual differentiation of monoaminergic neuron genetic epigenetic. Trends Neurosci 1991, 14:468-473.
108. Rondot P., Ziegler M. Dystonia - Levodopa responsive or juvenile parkinsonism?. J Neural Transm Suppl 1983, 19:273-281.
109. Rondot P., Aicardi J., Goutieres F., et al. [Dopa-sensitive dystonia]. Rev Neurol (Paris) 1992, 148:680-686.
110. Roze E., Vidailhet M., Blau N., et al. Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency. Mov Disord 2006, 21:263-266.
111. Sato K., Sumi-Ichinose C., Kaji R., et al. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008, 105:12551-12556.
112. Sawle G.B., Lenders K.L., Brooks D.J., et al. Dopa-responsive dystonia: [F-18] Dopa positron emission tomography. Ann Neurol 1991, 30:24-30.
113. Scherer-Oppliger T., Matasovic A., Laufs S., et al. Dominant negative allele (N47D) in a compound heterozygote for a variant of 6-pyruvoyltetrahydropterin synthase deficiency causing transient hyperphenylalaninemia. Hum Mutat 1999, 13:286-289.
114. Segawa M. [Hereditary progressive dystonia with marked diurnal fluctuation (HPD)]. Adv Neurol Sci (Tokyo) 1981, 25:73-81.
115. Segawa M. Development of the nigrostriatal dopamine neuron and the pathways in the basal ganglia. Brain Dev 2000, 22:1-4.
116. Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 2000, 22:65-80.
117. Segawa M. Discussant - pathophysiologies of Rett syndrome. Brain Dev 2001, 23:218-223.
118. Segawa M. Progress in Segawa's disease. Mapping the Progress of Alzheimer's Disease and Parkinson's Disease 2002, 353-359. Kluwer Academic/Plenum, New York. Y. Mizuno, A. Fisher, I. Hanin (Eds.).
119. Segawa M., Nomura Y. Rapid eye movements during stage REM are modulated by nigrostriatal dopamine (NS DA) neuron?. The Basal Ganglia III 1991, 663-671. Kluber Academic/Plenum Publishers, New York. G. Bernardi, M.B. Carpenter, G. Di Chiara (Eds.).
120. Segawa M., Nomura Y. Hereditary progressive dystonia with marked diurnal fluctuation. Pathophysiological importance of the age of onset. Adv Neurol 1993, 60:568-576.
121. Segawa M., Nomura Y. Pathophysiology of autism: evaluation of sleep and locomotion. Autism: A Neurological Disorder of Early Brain Development. International Review of Child Neurology Series (ICNA) 2006, 248-264. Mac Keith Press, London. R. Tuchman, I. Rapin (Eds.).
122. Segawa M., Ohmi K., Itoh S., et al. [Childhood basal ganglia disease with remarkable response to Levodopa, hereditary basal ganglia disease with marked diurnal fluctuation]. Shinryo (Tokyo) 1971, 24:667-672.
123. Segawa M., Hosaka A., Miyagawa F., et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976, 14:215-233.
124. Segawa M., Nomura Y., Kase M. Diurnally fluctuating hereditary progressive dystonia. Handbook of Clinical Neurology. Extrapyramidal Disorders 1986, 529-539. Elsevier, Amsterdam, Vol. 5. P.J. Vinken, G.W. Bruyn (Eds.).
125. Segawa M., Nomura Y., Hikosaka O., et al. Roles of the basal ganglia and related structures in symptoms of dystonia. The Basal Ganglia VI 1987, 489-504. Kluwer Academic/Plenum Publishers, New York. M.B. Carpenter, A. Jayaraman (Eds.).
126. Segawa M., Nomura Y., Takita K., et al. Pallidotomy and thalamotomy on a case with hereditary progressive dystonia with marked diurnal fluctuation. Mov Disord 1998, 13:165.
127. Segawa M., Nomura Y., Tanaka S., et al. Hereditary progressive dystonia with marked diurnal fluctuation: Consideration on its pathophysiology based on the characteristics of clinical and polysomnographical findings. Adv Neurol 1988, 50:367-376.
128. Segawa M., Nomura Y., Yamashita S., et al. Long term effects of Levodopa on hereditary progressive dystonia with marked diurnal fluctuation. Motor Disturbance II 1990, 305-318. Academic Press, London, New York. R. Benecke, A. Berardelli, M. Manfredi (Eds.).
129. Segawa M., Hoshino K., Hachimori K., et al. A single gene for dystonia involves both or either of the two striatal pathway. The Basal Ganglia VI 2002, 155-163. Kluwer Academic/Plenum Publishers, New York. L. Bicholson, R. Baull (Eds.).
130. Segawa M., Nomura Y., Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase i deficiency (segawa disease). Ann Neurol 2003, 54:32-45.
131. Shima F., Sakata S., Sun S.-J., et al. The role of the descending pallido-reticular pathway in movement disorders. Age-Related Dopamine-Dependent Disorders 1995, 197-207. Karger, Basel. M. Segawa, Y. Nomura (Eds.).
132. Shimoji M., Hirayama K., Hyland K., et al. GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice. J Neurochem 1999, 72:757-764.
133. Shimoyamada Y., Yoshikawa A., Kashii H., et al. [Hereditary progressive dystonia - an observation of the catecholamine metabolism during Levodopa therapy in a 9-year-old girl]. No-To-Hattatsu (Tokyo) 1986, 18:505-509.
134. Shimura H., Hattori N., Kubo S., et al. Familial Parkinson's disease gene product, Parkin, is a ubiquitin-protein ligase. Nat Genet 2000, 25:302-305.
135. Shintaku H. [Metabolic disorders of phenylalanine]. Jap J Pediatric Med 2009, 41:334-430.
136. Snow B.J., Okada A., Martin W.R.W., et al. Positron-emission tomography scanning in dopa-responsive dystonia, parkinsonism-dystonia, and young onset parkinsonism. Hereditary Progressive Dystonia with Marked Diurnal Fluctuation 1993, 181-186. Parthenon, Carnforth. M. Segawa (Ed.).
137. Sumi-Ichinose C., Urano F., Kuroda R., et al. Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem 2001, 276:41150-41160.
138. Sunohara N., Mano Y., Ando K., et al. Idiopathic dystonia: parkinsonism with marked diurnal fluctuation of symptoms. Ann Neurol 1985, 17:39-45.
139. Sunohara N., Ikeda K., Tomi H. Idiopathic dystonia-parkinsonism with diurnal fluctuation: a follow-up study and magnetic resonance imaging findings. Hereditary Progressive Dystonia with Marked Diurnal Fluctation 1993, 61-70. Parthenon, Carnforth. M. Segawa (Ed.).
140. Suzuki T., Ohye T., Inagaki H., et al. Characterization of wild-type and mutants of recombinant human GTP cyclohydrolase I: relationship to etiology of dopa-responsive dystonia. J Neurochem 1999, 73:2510-2516.
141. Takahashi H., Levine R.A., Galloway M.P., et al. Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol 1994, 35:354-356.
142. Takahashi H., Snow B., Nygaard T., et al. Fluorodopa PET scans of juvenile parkinsonism with prominent dystonia in relation to dopa-responsive dystonia. Age-Related Dopamine-Dependent Disorders 1995, 86-94. Karger, Basel. M. Segawa, Y. Nomura (Eds.).
143. Tanaka S., Miyagawa F., Imai H., et al. [Learning abilities of the rats with lesion in the dorsal noradrenergic bundele]. Juntendo Med J (Tokyo) 1987, 33:271-272.
144. Tanaka Y., Matsuo N., Tsuzaki S., et al. On-off phenomenon in a child with tetrahydrobiopterin deficiency due to 6-pyruvoyl tetrahydropterin synthase deficiency (BH4 deficiency). Eur J Pediatr 1989, 148:450-452.
145. Tassin J., Durr A., Bonnet A.-M., et al. Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations?. Brain 2000, 123:1112-1121.
146. Thony B., Blau N. Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes. Hum Mutat 1997, 10:11-20.
147. Turjanski N., Weeks R., Sawle G.V., et al. Positron emission tomography studies of the dopaminergic and opioid function in dopa-responsive dystonia. Age-Related Dopamine-Dependent Disorders 1995, 77-86. Karger, Basel. M. Segawa, Y.M. Nomura (Eds.).
148. Ueno S., Hirano M. Missense mutants inactivate guanosine triphosphate cyclohydrolase I in hereditary progressive dystonia. Brain Dev 2000, 22:111-114.
149. Valzelli L., Garattini S. Biochemical and behavioural changes induced by isolation in rats. Neuropharmacology 1972, 11:17-22.
150. Van Hove J.L., Steyaert J., Matthijis G., et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurosurg Psychiatry 2006, 77:18-23.
151. Wevers R.A., de Rijk-van Andel J.F., Brautigam C., et al. A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delc). J Inherit Metab Dis 1999, 22:364-373.
152. Wider C., Melquist S., Hauf M., et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH-1: redefining DYT14 as DYT5. Neurology 2008, 70:1377-1383.
153. Yamamura Y., Sobue I., Ando K., et al. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 1973, 23:239-244.
154. Yamamura Y., Hamaguchi Y., Uchida M., et al. Parkinsonism of early-onset with diurnal fluctuation. Hereditary Progressive Dystonia with Marked Diurnal Fluctation 1993, 51-59. Parthenon, Carnforth. M. Segawa (Ed.).
155. Yokochi M. Clinicopathological identification of juvenile parkinsonism in reference to dopa-responsive disorders. Hereditary Progressive Dystonia with Marked Diurnal Fluctation 1993, 37-47. Parthenon, Carnforth. M. Segawa (Ed.).